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Background: Prunus yedoensis Matsum. is used as traditional medicine—‘Yaeng-Pi’ or ‘Hua-Pi’—in Japan and Korea.
However, no studies have examined the pharmacological activities of the P. yedoensis bark. Only the antioxidant
and antiviral activities of P. yedoensis fruit and the anti-hyperglycaemic effect of P. yedoensis leaf have been
investigated. While studying the antihypertensive effects of several medicinal plants, we found that a methanol
extract of P. yedoensis bark (MEPY) had distinct vasorelaxant effects on rat aortic rings.
Methods: The aortic rings were removed from Sprague–Dawley rats and suspended in organ chambers containing
10 ml Krebs-Henseleit solution. The aortic rings were placed between 2 tungsten stirrups and connected to an
isometric force transducer. Changes in tension were recorded via isometric transducers connected to a data
acquisition system.
Results: MEPY relaxed the contraction induced by phenylephrine (PE) both in endothelium-intact and endothelium-
denuded aortic rings concentration dependently. However, the vasorelaxant effects of MEPY on endothelium-denuded
aortic rings were lower than endothelium-intact aortic rings. The vasorelaxant effects of MEPY on endothelium-intact
aortic rings were reduced by pre-treatment with L-NAME, methylene blue, or ODQ. However, pre-treatment with
indomethacin, atropine, glibenclamide, tetraethylammonium, or 4-aminopyridine had no affection. In addition, MEPY
inhibited the contraction induced by extracellular Ca2+ in endothelium-denuded rat thoracic aorta rings pre-contracted
by PE (1 μM) or KCl (60 mM) in Ca2+-free solution.
Conclusions: Our results suggest that MEPY exerts its vasorelaxant effects via the activation of NO formation by means of
L-Arg and NO-cGMP pathways and via the blockage of extracellular Ca2+ channels.Background
Prunus yedoensis Matsum (PY) is the most popular and
widely cultivated cherry tree in Japan and Korea [1,2].
The bark of PY has been used in traditional medicine -
‘Yaeng-Pi’ or ‘Hua-Pi’ [3]- to treat cough, urticaria, prur-
itus, dermatitis [4], asthma, and measles [3]. However,
no studies have examined the pharmacological activities
of PY bark. Only the antioxidant and antiviral activities
of PY fruit [5] and the anti-hyperglycaemic effect of PY
leaf [6] have been investigated.
While conducting an in vitro screening study of
various medicinal plants of vasorelaxant effect on the
isolated rat thoracic aorta rings using organ chamber
technique, PY bark was found to exhibit distinct vasore-
laxant activity. The effects of PY bark on the vascular* Correspondence: hychoi@khu.ac.kr
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reproduction in any medium, provided the orsystem have not been studied previously. Therefore, the
present study was designed to examine the vasorelaxant
effect of a methanol extract of PY bark (MEPY) on
isolated rat thoracic aortic rings.Methods
Plant material and extraction
P. yedoensis bark was purchased from Dongwoodang
Co., Ltd. (Yeongcheon, Kyungpook, Republic of Korea)
in June 2007. Professor Hocheol Kim of Kyung Hee
University identified the plants. A voucher specimen
P. yedoensis bark (PY001) was deposited at the College
of Korean Medicine, Kyung Hee University, Seoul,
Republic of Korea. Dried P. yedoensis bark (3 kg) was
extracted 3 times with 100% MeOH for 3 h in a reflux
apparatus. After reflux and filtration, the extract was
evaporated using a rotary vacuum evaporator (N-N
series, EYELA, Japan) at 60C and lyophilized to yield
386.8 g of crude extract. MEPY (1 g) was dissolved in
dimethyl sulfoxide (DMSO; 10 ml).. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Phenylephrine (PE), acetylcholine (ACh), Nω-Nitro-L-ar-
ginine methyl ester (L-NAME), methylene blue (MB),
atropine, indomethacin, ethylene glycol-bis (β-aminoethyl
ether)-N,N,N’,N’-tetraacetic acid (EGTA), tetraethylammo-
nium (TEA), glibenclamide, 4-aminopyridine (4-AP), 1-H-
[1,2,4]-oxadiazolo-[4,3-α]-quinoxalin-1-one (ODQ), and
DMSO were purchased from Sigma Aldrich (St. Louis,
USA). All other reagents were of analytical purity.
Preparation of rat aortic rings
All procedures involving animals were conducted
according to the animal welfare guidelines issued by
National Veterinary Research & Quarantine Service and
World Organization for Animal Health (OIE); and this
study was approved (KHUASP(SE)-10-028) by the
Kyung Hee University Institutional Animal Care and
Use Committee. The rats were housed under controlled
conditions (22 ± 2C; lighting, 07:00–19:00), and food
and water were available ad libitum. Sprague–Dawley
rats (weight, 240–260 g; Narabio, Seoul, Korea) were
anesthetized by exposure to ether, and the thoracic
aorta was removed and immersed in Krebs-Henseleit
solution [K-H solution, composition (mM): NaCl, 118.0;
KCl, 4.7; MgSO4, 1.2; KH2PO4, 1.2; CaCl2, 2.5;
NaHCO3, 25.0; and glucose, 11.1; pH 7.4], maintained
at 37C, and aerated with a mixture of 95% O2 and 5%
CO2. After connective tissue and fat were carefully
removed, approximately 2-mm-long aortic rings were
cut and suspended in organ chambers containing
10 ml K-H solution at 37C. The rings in the chambers
were aerated with a mixture of 95% O2 and 5% CO2.
The aortic rings were placed between 2 tungsten stir-
rups and connected to an isometric force transducer
(Grass Instrument Co., Rhode Island, USA). After
incubation under no tension for 30 min, the vessel seg-
ments were allowed to equilibrate for 1 h at a restingFigure 1 Concentration-dependent relaxant effects of MEPY on phen
without [(E-)] endothelium (A) in Krebs-Henseleit solution. Control gro
aortic rings with [(E+)] (B) or without [(E-)] endothelium (C). The relaxant e
percentage of the contraction in response to PE. Values are expressed as mtension of 1.0 g. The K-H solution was replaced every
15 min during the equilibration period. Changes in ten-
sion were recorded via isometric transducers connected
to a data acquisition system (PowerLab, ADI instrument
Co., New South Wales, Australia). When required, the
endothelium was removed by gently rubbing the lumen
of the vessel with a thin cotton swab. The presence of
functional endothelium was verified by the ability of
ACh (10 μM) to induce more than 80% relaxation in
rings that were precontracted by PE (1 μM). In
endothelium-denuded rings, ACh caused less than 10%
relaxation. Ca2+-free K-H solution was prepared by
replacing CaCl2 with EGTA (1 mM).
Vasoactivity
We studied the concentration-dependent relaxant effect
of MEPY on endothelium-intact and endothelium-
denuded aortic rings that were pre-contracted with PE
(1 μM) in standard K-H solution. The relaxant effect of
MEPY on the aortic rings was calculated as a percentage
of the contraction in response to PE.
To study the effect of MEPY on nitric oxide (NO)
synthesis pathway, endothelium-intact aortic rings were
pre-incubated with L-NAME (10 μM) for 20 min before
contraction by PE (1 μM) treatment. The relaxant effect
of MEPY on the aortic rings was compared with the
control (not treated with L-NAME).
To investigate the effect of MEPY on the NO-cyclic
guanosine monophosphate (cGMP) pathway, endothelium-
intact aortic rings were pre-incubated with ODQ (10 μM)
or MB (10 μM) for 20 min before contraction by PE
(1 μM) treatment. The relaxant effect of MEPY on the
aortic rings was compared with the control (not treated
with ODQ or MB).
To determine whether prostacyclin is involved in
MEPY-induced vasorelaxation, endothelium-intact aortic
rings were pre-incubated with indomethacin (1 μM) forylephrine (PE, 1 μM)-pre-contracted rat aortic rings with [(E+)] or
ups were not treated with MEPY. The MEPY induced-relaxant traces of
ffects of MEPY on isolated rat aortic rings were calculated as a
ean ± SEM (n = 8). *P < 0.05, **P < 0.01 vs. MEPY E (−).
Figure 2 Relaxation responses induced by MEPY in endothelium-
intact rat aortic rings pre-contracted with phenylephrine (PE,
1 μM) in the presence or absence (control) of Nω-Nitro-L-arginine
methyl ester (L-NAME, 10 μM), methylene blue (MB, 10 μM), or
1-H-[1,2,4]-oxadiazolo-[4,3-α]-quinoxalin-1-one (ODQ, 10 μM) in
Krebs-Henseleit solution. The relaxant effects of MEPY on isolated
rat aortic rings were calculated as a percentage of the contraction in
response to PE. Values are expressed as mean ± SEM (n = 6–8).
*P < 0.05, **P < 0.01 vs. control.
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relaxant effect of MEPY on the aortic rings was com-
pared with the control (not treated with indomethacin).
To determine whether enhanced NO release by MEPY
was associated with the activation of muscarinic recep-
tors, endothelium-intact aortic rings were pre-incubated
with atropine (1 μM) for 20 min before contraction by
PE (1 μM) treatment. The relaxant effect of MEPY on
the aortic rings was compared with the control (not
treated with atropine).
To determine whether K+ channels are involved in
MEPY-induced vasorelaxation, endothelium-intact aortic
rings in standard K-H solution were pre-incubated with
various K+ channel blockers, TEA (5 mM), glybenclamide
(10 μM), or 4-AP (1 mM) for 20 min before the addition
of PE (1 μM). Once a plateau was attained, MEPY (1–
100 μg/ml) was cumulatively added. The vasorelaxant
effect of MEPY on the aortic rings was calculated as a per-
centage of the contraction in response to PE.
To investigate the effect of MEPY on extracellular
Ca2+-induced contractions, we carried out 2 sets of
experiments: (1) evaluation of receptor-operative Ca2+
channels (ROCCs) and (2) evaluation of voltage-
dependent Ca2+ channels (VDCCs). In the experiment on
ROCCs, we investigated the contractile response induced
by CaCl2 (0.3–10 mM) in the endothelium-denuded aortic
rings contracted by PE (1 μM) in Ca2+-free K-H solution
with and without (control) a 10-min preincubation with
MEPY (200 μg/ml). The experiment on VDCCs followed
the same procedure, except that the contraction was
induced by KCl (60 mM). The contractile responses
induced by CaCl2 in the presence and absence (control) of
MEPY pre-treatment were compared.Data analysis
Data are expressed as mean ± standard error of mean
(SEM). Statistical comparisons were made using Student’s
t-test or one-way analysis of variance (ANOVA) followed
by the Tukey’s post-hoc test. All statistical analyses were
performed using SPSS v.13.0 statistical analysis software
(SPSS Inc., USA). P values less than 0.05 were considered
statistically significant.Figure 3 Relaxation responses induced by MEPY in
endothelium-intact rat aortic rings pre-contracted with
phenylephrine (PE, 1 μM) in the presence or absence (control)
of indomethacin (1 μM) or atropine (1 μM) in Krebs-Henseleit
solution. The relaxant effects of MEPY on isolated rat aortic rings
were calculated as a percentage of the contraction in response to
PE. Values are expressed as mean ± SEM (n = 4–8).Results
Effect of MEPY on PE-induced contraction of
endothelium-intact or endothelium-denuded aortic rings
MEPY caused concentration-dependent relaxation in
both endothelium-intact and endothelium-denuded aor-
tic rings pre-contracted by PE (1 μM) treatment. How-
ever, endothelium-intact aortic rings were more relaxed
than endothelium-denuded aortic rings. The maximal
relaxant effect was 94.0% ± 2.7% and 49.4% ± 0.7% forendothelium-intact and endothelium-denuded aortic
rings, respectively (Figure 1).Effect of MEPY on endothelium-intact aortic rings
pre-incubated with L-NAME, MB, or ODQ
Incubation with L-NAME (10 μM), MB (10 μM), or ODQ
(10 μM) significantly decreased MEPY-induced relaxation
of endothelium-intact aortic rings pre-contracted by PE
Figure 4 Relaxation responses induced by MEPY in
endothelium-intact rat aortic rings pre-contracted with
phenylephrine (PE, 1 μM) in the presence or absence (control)
of glibenclamide (10 μM), tetraethylammonium (TEA, 5 mM), or
4-aminopyridine (4-AP, 1 mM) in Krebs-Henseleit solution. The
relaxant effects of MEPY on isolated rat aortic rings were calculated
as a percentage of the contraction in response to PE. Values are
expressed as mean ± SEM (n = 6–8).
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ODQ, the maximal relaxant effect was 94.0% ± 2.7%. In
the presence of L-NAME, MB, and ODQ, the maximal re-
laxant effect was 28.1% ± 5.9%, 69.2% ± 6.5%, and 34.5% ±
0.6%, respectively (Figure 2).Effect of MEPY on endothelium-intact aortic rings
pre-incubated with indomethacin or atropine
Incubation with indomethacin (1 μM), a non-selective
cyclooxygenase (COX) inhibitor, did not affect MEPY-
induced relaxation of endothelium-intact aortic rings
pre-contracted by PE (1 μM) treatment (Figure 3).Figure 5 Inhibitory effect of MEPY (200 μg/ml) on the contraction ind
denuded rat aortic rings pre-contracted by phenylephrine (PE, 1 μM)
Values are expressed as mean ± SEM (n = 5–7). *P < 0.05, **P < 0.01 vs. contrEffect of MEPY on endothelium-intact aortic rings
pre-incubated with various K+ channel blockers
The vasorelaxant effects of MEPY on PE (1 μM)-pre-
contracted endothelium-intact aortic rings were not
altered by incubation of the rings with various K+ channel
blockers, including glibenclamide (10 μM), tetraethylam-
monium (TEA, 5 mM), or 4-aminopyridine (4-AP, 1 mM)
(Figure 4).Effect of MEPY on extracellular Ca2+-induced contraction
In Ca2+-free K–H solution, the cumulative addition of
CaCl2 (0.3–10 mM) induced progressively increased ten-
sion in the rat aortic rings pre-contracted by PE (1 μM;
Figure 5A) or KCl (60 mM; Figure 5B) treatment. As
shown in Figure 5, MEPY (200 μg/ml) pre-incubation for
20 min significantly inhibited the contraction induced by
extracellular CaCl2.Discussion
In the present study, MEPY showed relaxant effects on
both PE- and KCl-pre-contracted endothelium-intact and
endothelium-denuded aortic rings. However, the relaxant
effects of MEPY on endothelium-denuded aortic rings were
reduced. These findings suggested that the relaxant effects
caused by MEPY were both endothelium-dependent and
endothelium-independent. Thus, we clarified the mecha-
nisms of MEPY on rat aortic rings through endothelium
dependent pathway in addition to endothelium independ-
ent pathway. Thus, the main findings were as follows: (1)
the vasorelaxant effect of MEPY was related to activation of
nitric oxide (NO) formation from L-arginine (L-Arg) and
the NO-cGMP pathway; (2) vasoactive prostacyclin (PGI2)
and muscarinic receptors and K+ channels did not contrib-
ute to MEPY-induced vasorelaxation; (3) MEPY relaxed theuced by extracellular Ca2+ addition (0.3–10 mM) in endothelium-
(A) or KCl (60 mM) (B) in Ca2+-free Krebs-Henseleit solution.
ol.
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via ROCCs and VDCCs.
The vascular endothelium plays an important role in
vasorelaxation via the secretion of potent vasodilators such
as NO, PGI2, and endothelium-derived hyperpolarizing
factor (EDHF). In endothelial cells, the calcium-calmodulin
complex stimulates NO synthase (NOS), which activates
NO formation from L-Arg. In the smooth muscle cells,
NO stimulates soluble guanylate cyclase, which increases
intracellular cGMP; this increase then activates cGMP-
dependent protein kinases leading to a decrease in
the calcium concentrations in the smooth muscle cells.
Vascular smooth muscle is relaxed via these pathways [7].
To investigate the involvement of endothelium-derived
vasodilators, the effects of various inhibitors of MEPY-
induced relaxation were examined. The vasorelaxant effect
of MEPY was reduced by pre-treatment with L-NAME, an
inhibitor of NOS. Moreover, pre-treatment with MB
or ODQ, which are soluble guanylate cyclase inhibitors,
reduced the vasorelaxant effects of MEPY. These findings
suggested that the vasorelaxant effect of MEPY is
related to activation of NO formation from L-arginine and
NO-cGMP pathway.
However, pre-treatment with indomethacin, a non-
selective cyclooxygenase (COX) inhibitor did not affect
the vasorelaxant effects of MEPY. PGI2 is synthesized by
COX in the endothelial cells, and it activates adenyl
cyclase (AC). It causes an increase in the intracellular con-
centrations of cyclic adenosine monophosphate (cAMP),
which leads to vasodilation by decreasing intracellular
calcium concentrations in the vascular smooth muscle [7].
This finding suggested that PGI2 may not contribute to
MEPY-induced vasorelaxation.
In addition, pre-treatment with atropine, a non-
selective muscarinic receptor antagonist did not affect
the vasorelaxant effects of MEPY. This suggested that
MEPY did not interact with the muscarinic receptors in
MEPY-induced vasorelaxation.
The vasorelaxant effects of MEPY were not affected by
pre-treatment with various K+ channel blockers. The open-
ing of K+ channels in vascular smooth muscle cells is a
major mechanism involved in the regulation of muscle
contractility and vascular tone [8]. TEA (a blocker of large
conductance Ca2+-activated K+ channels), glybenclamide
(a selective inhibitor of ATP-sensitive K+ channels), and 4-
AP (a suppressant of voltage-gated K+ channels) are well-
known K+ channel blockers used to investigate potential K+
channel-related vasorelaxant effects of various agents. Our
findings indicated that the relaxant effect of MEPY on the
rat aortic rings is not related to the opening of K+ channels.
In the present study, removal of the functional endo-
thelium and pre-treatment with L-NAME reduced but
did not abolish the relaxant effects of MEPY. Therefore,
we concluded that MEPY-induced vasorelaxation alsoinvolves endothelium-independent pathway. Vascular
smooth muscles play an important role in vasorelaxation,
which is regulated by the influx of extracellular Ca2+ via
transmembrane Ca2+ channels [9]. The influx of extracel-
lular Ca2+ is mainly regulated by ROCCs or VDCCs [10].
MEPY (200 μg/ml) inhibited vasoconstriction induced by
Ca2+ supplementation in the aortic rings that had been
pre-contracted with PE (1 μM) in Ca2+-free K–H solution,
suggesting that MEPY inhibits the entry of extracellular
Ca2+ via ROCCs activated by PE. And, MEPY also inhib-
ited the vasocontraction induced by Ca2+ supplementation
in the aortic rings that had been pre-contracted with KCl
(60 mM) in Ca2+-free K–H solution, suggesting that
MEPY inhibits the entry of extracellular Ca2+ via VDCCs
activated by KCl.
Conclusions
Our findings suggested that vasorelaxant mechanisms
responsible for the hypotensive effects of MEPY include
endothelium-dependent and endothelium-independent
pathways involving activation of NO formation from L-
Arg and NO-cGMP pathway, blocking the entry of
extracellular Ca2+ via ROCCs and VDCCs. These find-
ings may explain the medicinal use of P. yedoensis bark
in hypertension. However, more detailed mechanism
studies, in vivo studies and isolation of the potent vasore-
laxant single compound from MEPY may be necessary to
establish the precise efficacy of MEPY on hypertension.
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